Investigators analyzed mRNA expression data of 111 patients with Merkel cell carcinoma (MCC) and performed immunohistochemical analysis to detect the expression of programmed death ligand 1, CD8, FOXP3, TIGIT, and CD155 in 65 cases of MCC.
[Scientific Reports]